| September 1, 2011 --
San Diego -- Volcano Corporation (NASDAQ: VOLC), a leading developer and
manufacturer of precision intravascular diagnosis and therapy
guidance tools designed to enhance the treatment of coronary
and peripheral vascular disease, said today that it will be participating
in two upcoming investor conferences.
On Wednesday, September 7, the company will participate in the Stifel
Nicolaus Healthcare Conference 2011. The presentation by John Dahldorf,
chief financial officer, will begin at 2:05 p.m., Eastern Daylight Time
(11:05 a.m., Pacific Daylight Time). The presentation will be available
through the conference website at http://www.veracast.com/webcasts/stifel/
healthcare2011/86111211.cfm and
via the company's website at www.volcanocorp.com.
|
